AcuityBio Overview

  • Founded
  • 2008
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 3
Employees
  • Latest Deal Type
  • M&A
  • Investors
  • 1

AcuityBio General Information

Description

Developer of bio-compatible and biodegradable drug-eluting surgical products designed to commercialize novel polymer drug delivery technologies. The company's products are implemented with safety and efficacy in preclinical models, long-term targeted delivery of therapeutic levels of paclitaxel to areas at highest risk for harboring residual cancer cells and can be applied to additional indications besides lung cancer, enabling surgeons to administer during initial tumor removal surgery and prevent a recurrence.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Other Industries
Drug Delivery
Biotechnology
Acquirer
Cook Biotech
Primary Office
  • 321 Walnut Street
  • Suite 300
  • Newton, MA 02460
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AcuityBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 18-Jun-2021 00.000 Completed Generating Revenue
6. Later Stage VC 10-Feb-2020 00000 00.000 000.00 Completed Generating Revenue
5. Later Stage VC (Series A) 13-Nov-2017 00.000 00.000 000.00 Completed Generating Revenue
4. Grant 00000 Completed Generating Revenue
3. Grant 01-Jul-2013 00000 Completed Generating Revenue
2. Grant 16-Sep-2011 $1.4M Completed Generating Revenue
1. Grant 01-Jan-2008 $500K Completed Startup
To view AcuityBio’s complete valuation and funding history, request access »

AcuityBio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.00
To view AcuityBio’s complete cap table history, request access »

AcuityBio Patents

AcuityBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2017511238-A Delivery system for placing and affixing a surgical mesh or surgical buttress over a resection edge Granted 08-Apr-2014 0000000000
JP-6654623-B2 Delivery system for placing and gluing a surgical mesh or surgical buttress over a resection edge Active 08-Apr-2014 0000000000
CA-2945168-A1 Delivery system for positioning and affixing surgical mesh or surgical buttress covering a surgical margin Pending 08-Apr-2014 0000000000
AU-2015243525-A1 Delivery system for positioning and affixing surgical mesh or surgical buttress covering a surgical margin Granted 08-Apr-2014 0000000000
AU-2015243525-B2 Delivery system for positioning and affixing surgical mesh or surgical buttress covering a surgical margin Active 08-Apr-2014 A61F2/0063
To view AcuityBio’s complete patent history, request access »

AcuityBio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AcuityBio Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Internal Revenue Service Government 000 0000 000000 0
National Cancer Institute Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view AcuityBio’s complete investors history, request access »